Cargando…

Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients

BACKGROUND & OBJECTIVES: Lipoprotein-A has been recognized as a risk factor for ischemic heart diseases. Myocardial infarction (MI) is common complication of ischemic heart disease. Diabetes play an incremental role in the development of coronary artery disease (CAD), however still there are con...

Descripción completa

Detalles Bibliográficos
Autores principales: Nayyer-uz-Zaman, Dar, Muhammad Habeel, Adnan, Yasir, Noor, Lubna, Naz, Gul, Zahoor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954359/
https://www.ncbi.nlm.nih.gov/pubmed/29805388
http://dx.doi.org/10.12669/pjms.342.13848
_version_ 1783323504790208512
author Nayyer-uz-Zaman,
Dar, Muhammad Habeel
Adnan, Yasir
Noor, Lubna
Naz, Gul
Zahoor,
author_facet Nayyer-uz-Zaman,
Dar, Muhammad Habeel
Adnan, Yasir
Noor, Lubna
Naz, Gul
Zahoor,
author_sort Nayyer-uz-Zaman,
collection PubMed
description BACKGROUND & OBJECTIVES: Lipoprotein-A has been recognized as a risk factor for ischemic heart diseases. Myocardial infarction (MI) is common complication of ischemic heart disease. Diabetes play an incremental role in the development of coronary artery disease (CAD), however still there are conflicting data regarding the relationship of Lipoprotein-B and MI. We therefore wanted to evaluate the relationship of Lipo-B, MI and diabetes mellitus. Our objective was to determine the non-fasting Apo-lipoprotein B and triglycerides level among type II diabetic patients with ischemic heart disease and to compare with type II diabetic without ischemic heart disease. METHODS: This was cross sectional study where two groups of patients were recruited in the study, Group-I included patient with Ischemic Heart Disease and diabetes while Group-II comprised of diabetes without Ischemic Heart Disease. Age, sex and basic demographic matching was done between the two groups. Data were collected using random sample. The comparative approach was used to see the role of diabetes in the elevation of Apo-lipoprotein B level, which is a risk factor for Ischemic heart diseases. RESULTS: Two hundred forty eight patients (Cases: 123 Diabetic with myocardial infarction and (Control: 125 Diabetic without myocardial infarction) were included in the study. Mean Apo-B among diabetic patients with myocardial infarction was high (68.3±24.23 ng/ml) compared to non-cardiac patients (49.97±33.880 ng/ml) with a p <0.000. Marked difference was also observed in triglycerides levels where it was found very high (301.4±55.1 mg/dL) in patients of diabetes with myocardial infarction as compared to subjects without MI (137.7±84.7 mg/dL). There was positive correlation between Apo-lipoprotein and Triglycerides (P value=039). CONCLUSION: Based on the study result it was concluded that Apo-lipoprotein and triglycerides in diabetic patients with myocardial infarction, had higher levels compared to diabetic patients without Myocardial infarction and this could be a consequence of increase in age, insulin resistance and deficiency of insulin in the body. We also found positive correlation between Apo-lipoprotein and Triglycerides.
format Online
Article
Text
id pubmed-5954359
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Professional Medical Publications
record_format MEDLINE/PubMed
spelling pubmed-59543592018-05-25 Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients Nayyer-uz-Zaman, Dar, Muhammad Habeel Adnan, Yasir Noor, Lubna Naz, Gul Zahoor, Pak J Med Sci Original Article BACKGROUND & OBJECTIVES: Lipoprotein-A has been recognized as a risk factor for ischemic heart diseases. Myocardial infarction (MI) is common complication of ischemic heart disease. Diabetes play an incremental role in the development of coronary artery disease (CAD), however still there are conflicting data regarding the relationship of Lipoprotein-B and MI. We therefore wanted to evaluate the relationship of Lipo-B, MI and diabetes mellitus. Our objective was to determine the non-fasting Apo-lipoprotein B and triglycerides level among type II diabetic patients with ischemic heart disease and to compare with type II diabetic without ischemic heart disease. METHODS: This was cross sectional study where two groups of patients were recruited in the study, Group-I included patient with Ischemic Heart Disease and diabetes while Group-II comprised of diabetes without Ischemic Heart Disease. Age, sex and basic demographic matching was done between the two groups. Data were collected using random sample. The comparative approach was used to see the role of diabetes in the elevation of Apo-lipoprotein B level, which is a risk factor for Ischemic heart diseases. RESULTS: Two hundred forty eight patients (Cases: 123 Diabetic with myocardial infarction and (Control: 125 Diabetic without myocardial infarction) were included in the study. Mean Apo-B among diabetic patients with myocardial infarction was high (68.3±24.23 ng/ml) compared to non-cardiac patients (49.97±33.880 ng/ml) with a p <0.000. Marked difference was also observed in triglycerides levels where it was found very high (301.4±55.1 mg/dL) in patients of diabetes with myocardial infarction as compared to subjects without MI (137.7±84.7 mg/dL). There was positive correlation between Apo-lipoprotein and Triglycerides (P value=039). CONCLUSION: Based on the study result it was concluded that Apo-lipoprotein and triglycerides in diabetic patients with myocardial infarction, had higher levels compared to diabetic patients without Myocardial infarction and this could be a consequence of increase in age, insulin resistance and deficiency of insulin in the body. We also found positive correlation between Apo-lipoprotein and Triglycerides. Professional Medical Publications 2018 /pmc/articles/PMC5954359/ /pubmed/29805388 http://dx.doi.org/10.12669/pjms.342.13848 Text en Copyright: © Pakistan Journal of Medical Sciences http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Nayyer-uz-Zaman,
Dar, Muhammad Habeel
Adnan, Yasir
Noor, Lubna
Naz, Gul
Zahoor,
Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients
title Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients
title_full Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients
title_fullStr Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients
title_full_unstemmed Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients
title_short Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients
title_sort nonfasting apo-lipoprotein b and triglyceride levels as a predictor of coronary heart disease in type ii diabetic patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954359/
https://www.ncbi.nlm.nih.gov/pubmed/29805388
http://dx.doi.org/10.12669/pjms.342.13848
work_keys_str_mv AT nayyeruzzaman nonfastingapolipoproteinbandtriglyceridelevelsasapredictorofcoronaryheartdiseaseintypeiidiabeticpatients
AT darmuhammadhabeel nonfastingapolipoproteinbandtriglyceridelevelsasapredictorofcoronaryheartdiseaseintypeiidiabeticpatients
AT adnanyasir nonfastingapolipoproteinbandtriglyceridelevelsasapredictorofcoronaryheartdiseaseintypeiidiabeticpatients
AT noorlubna nonfastingapolipoproteinbandtriglyceridelevelsasapredictorofcoronaryheartdiseaseintypeiidiabeticpatients
AT nazgul nonfastingapolipoproteinbandtriglyceridelevelsasapredictorofcoronaryheartdiseaseintypeiidiabeticpatients
AT zahoor nonfastingapolipoproteinbandtriglyceridelevelsasapredictorofcoronaryheartdiseaseintypeiidiabeticpatients